Hormones are the single most powerful biological influence on whether your hair grows thick, thins out, or falls away entirely. Androgens like testosterone and its derivative DHT are the main drivers of pattern baldness in both men and women, but they are far from the only hormones involved. Thyroid hormones, estrogen, cortisol, prolactin, insulin-like growth factor, and even melatonin all act on hair follicles in distinct ways, sometimes pushing growth and sometimes shutting it down. The relationship is complex enough that the same hormone can make hair flourish in one part of your body while causing it to miniaturize and vanish from another.
How Androgens Drive Pattern Hair Loss
Androgenetic alopecia, the receding hairlines and thinning crowns most people picture when they think of hair loss, is fundamentally a hormonal condition. The key molecule is dihydrotestosterone (DHT), which is converted from testosterone by an enzyme called 5-alpha reductase. DHT binds to androgen receptors inside dermal papilla cells, the signaling hub at the base of each hair follicle.1PubMed Central. Hormonal Effects on Hair Follicles When those receptors are activated on the scalp, the result is not good for your hair: follicles gradually shrink, producing thinner and shorter strands with each cycle until they eventually stop producing visible hair altogether.
Animal research has shown this process in action. When DHT was applied to mouse hair follicles, it induced early regression of the growth phase, miniaturization, and loss of hair density, closely mimicking the progression of human pattern baldness.2Biomedicine & Pharmacotherapy. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia What makes this particularly frustrating is that DHT does the opposite on the face and body, where it stimulates thicker, coarser hair growth. The difference comes down to how dermal papilla cells in different body regions respond to the same hormonal signal. Scalp follicles in susceptible areas read DHT as a shutdown command, while beard and chest follicles treat it as a growth signal.
Another piece of the puzzle involves prostaglandins, lipid molecules that work closely with androgens in the scalp. Researchers found that prostaglandin D2 is elevated in bald scalp tissue of men with androgenetic alopecia, and when its levels were artificially raised in mice, they developed hair loss, follicle miniaturization, and enlarged oil glands, all hallmarks of human pattern baldness.3PubMed Central. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia This finding opened up potential treatment avenues beyond simply blocking DHT.
Estrogen, Pregnancy, and Postpartum Shedding
If you have been pregnant, you may have noticed your hair looking unusually full during the second and third trimesters. That is estrogen at work. Elevated estrogen levels extend the growth phase of hair follicles, keeping more hairs in active production and reducing the normal daily shedding rate. The result is thicker-feeling hair, not because new follicles appeared, but because fewer hairs were falling out on schedule.
The flip side comes after delivery. As estrogen drops back to pre-pregnancy levels, all those hairs that had overstayed their growth phase enter the resting phase roughly at the same time, then fall out in a wave about two to three months later. This is called telogen effluvium, a diffuse shedding pattern triggered by hormonal shifts.4PubMed Central. Postpartum Telogen Effluvium Unmasking Traction Alopecia It feels alarming because the volume of hair loss can be dramatic, but in most cases the shedding is temporary and the hair gradually returns to its normal cycle. One thing worth knowing: this postpartum shedding can sometimes unmask an underlying hair loss condition, like female pattern hair loss, that was hidden while estrogen levels were high.
Thyroid Hormones and Hair Cycling
Your thyroid gland produces hormones (T3 and T4) that regulate metabolism throughout the body, and hair follicles are no exception. Both hyperthyroidism and hypothyroidism can cause widespread hair shedding.5PubMed Central. Impact of Thyroid Dysfunction on Hair Disorders The shedding tends to be diffuse rather than patterned, meaning you lose hair evenly across the scalp rather than in specific zones. Drug-induced hypothyroidism, from medications like lithium or amiodarone, can produce the same effect.
Research on human scalp follicles grown in the lab has shown why this happens at a cellular level. T4 stimulates the proliferation of the cells that build the hair shaft, while both T3 and T4 reduce the programmed cell death that normally ends the growth phase. T4 also appears to prolong the active growth phase itself, possibly by suppressing a key growth factor that signals the follicle to stop.6The Journal of Clinical Endocrinology & Metabolism. Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation So thyroid hormones in the right amounts help keep hair growing longer and thicker. Too much or too little disrupts that balance, and the follicles respond by prematurely shifting into rest and then shedding.
This is one reason dermatologists often check thyroid function in patients with unexplained hair loss. If a thyroid imbalance is the root cause, treating it generally allows hair to recover, though regrowth can take months since hair cycles are slow.
What Stress Hormones Do to Hair Follicles
The link between stress and hair loss is not just folklore. A landmark study in mice showed that corticosterone, the rodent equivalent of human cortisol, directly regulates hair follicle stem cells. Under chronic stress, elevated corticosterone keeps those stem cells in a prolonged resting state, preventing new hair growth cycles from starting. The mechanism is specific: the stress hormone acts on dermal papilla cells to suppress a signaling molecule called GAS6, which the stem cells need as a wake-up call to start producing new hair.7Nature. Corticosterone inhibits GAS6 to govern hair follicle stem-cell quiescence When researchers restored GAS6 expression artificially, hair growth resumed despite ongoing high stress hormone levels.
Interestingly, the relationship between glucocorticoids (the family of stress hormones that includes cortisol) and hair is not purely negative. A separate study found that glucocorticoid signaling in a specific type of immune cell, regulatory T cells, actually helps activate hair follicle stem cells and promote regeneration. When the glucocorticoid receptor in these immune cells was blocked, hair regeneration stalled, even though the rest of the immune system functioned normally.8Nature Immunology. Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche So cortisol’s role is not a simple “more stress equals more hair loss” equation. At normal, fluctuating levels, glucocorticoids participate in healthy hair cycling. It is the chronic elevation that tips the balance toward prolonged dormancy.
PCOS and the Double Bind of Androgen Excess
Polycystic ovary syndrome illustrates one of the crueler ironies of hormonal hair effects: the same condition can cause excessive hair growth on the face and body while simultaneously thinning hair on the scalp. PCOS is the most common cause of androgen excess in women, and hirsutism, the growth of coarse, dark hair in a male-type distribution, is its most visible sign. In the general population, hirsutism affects roughly 4 to 11 percent of women, but among women with PCOS the prevalence jumps to about 65 to 75 percent.9PubMed Central. Hirsutism, Normal Androgens and Diagnosis of PCOS
At the same time, the excess androgens can trigger female pattern hair loss on the scalp. A systematic review and meta-analysis estimated that about 28 percent of women with PCOS have female pattern hair loss.10The Journal of Clinical Endocrinology & Metabolism. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee So a woman with PCOS may be dealing with unwanted facial hair, thinning on the crown, and the frustration of both problems having the same underlying hormonal cause.11Best Practice & Research Clinical Obstetrics & Gynaecology. Androgen excess: Investigations and management Treatment usually involves addressing the androgen excess itself, sometimes with anti-androgen medications, hormonal contraceptives, or insulin-sensitizing drugs, since insulin resistance frequently accompanies PCOS and can amplify androgen production.
Less Obvious Hormonal Players
Beyond the well-known actors, several other hormones influence hair in ways that are still being mapped out.
Insulin-like growth factor 1 (IGF-1) acts as a growth signal in hair follicles, stimulating cell proliferation and helping regulate the hair cycle. It sits at a crossroads between androgen signaling and follicle health: androgen levels regulate IGF-1 production, and dermal papilla cells from balding scalp follicles secrete significantly less IGF-1 than their counterparts from non-balding areas.12PubMed Central. Further Clinical Evidence for the Effect of IGF-1 on Hair Growth and Alopecia This makes IGF-1 one of the downstream messengers through which androgens execute their effects on hair.
Prolactin, best known for its role in lactation, is also produced locally by hair follicles themselves. When researchers exposed human scalp follicles to high concentrations of prolactin in the lab, it slowed hair shaft growth, pushed follicles into early regression, and increased cell death at the hair bulb.13PubMed Central. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression This may help explain why people with hyperprolactinemia, a condition of chronically elevated prolactin often caused by pituitary tumors, sometimes experience hair loss that was previously poorly understood.
Growth hormone has a paradoxical relationship with hair. Excess growth hormone, as seen in acromegaly, is associated with increased body hair growth and sometimes hirsutism in women. But when recombinant growth hormone was applied to female human scalp follicles in the lab, it actually inhibited growth, likely by ramping up a signal that promotes the regression phase.14PubMed Central. Growth Hormone and the Human Hair Follicle Meanwhile, people with Laron syndrome, who lack functional growth hormone receptors, tend to have thin hair and prominent follicle defects. Growth hormone clearly matters for hair, but the effects depend heavily on the dose, the body site, and the broader hormonal context.
Melatonin, the hormone that regulates your sleep-wake cycle, has also been studied for hair effects. In a study of 35 men with androgenetic alopecia using topical melatonin, hair density increased by about 29 percent at three months and 41 percent at six months compared to baseline. A much larger multicenter study with more than 1,800 volunteers found that the proportion of participants with a negative hair-pull test (meaning minimal shedding) jumped from about 12 percent to over 61 percent after three months of topical melatonin.15PubMed Central. Topical Melatonin for Treatment of Androgenetic Alopecia The mechanism is not fully understood, but melatonin has antioxidant properties and may influence follicle cycling through pathways that intersect with other hormonal signals.
Your Skin Makes Its Own Hormones
One reason the hormonal picture is so complicated is that your skin does not just passively receive hormones from the bloodstream. It actively manufactures them. The skin synthesizes significant amounts of sex hormones locally, with sebaceous glands and sweat glands being the major producers.16PubMed. Sexual hormones in human skin This means that the hormonal environment around a given hair follicle depends partly on circulating hormones and partly on what the surrounding tissue is producing on its own. It also explains why systemic blood tests for hormone levels do not always tell the full story in hair loss. A person with normal circulating androgen levels can still experience androgenetic alopecia if local enzyme activity is converting more testosterone to DHT right at the follicle.
The scalp’s immune environment adds another layer. Inflammation and oxidative stress can disrupt follicle function and damage the tissue surrounding hair roots, while imbalances in the scalp’s microbial community can destabilize the local chemical environment in ways that interact with hormonal signaling.17PubMed. Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia Hair loss, in other words, is rarely the product of a single hormone acting alone. It is typically the result of hormones, immune cells, local metabolism, and genetic susceptibility all converging at the follicle.
What Gender-Affirming Hormone Therapy Reveals
Gender-affirming hormone therapy (GAHT) provides something close to a natural experiment in how shifting the body’s dominant hormonal environment reshapes hair growth. A systematic review of the literature found that feminizing therapy with estradiol and anti-androgens in transgender women can reduce facial and body hair growth and improve androgenetic alopecia, while masculinizing therapy with testosterone in transgender men can increase facial and body hair and trigger or accelerate pattern hair loss.18PubMed. Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature
A prospective study tracking scalp hair over 24 weeks confirmed some of these trends with objective measurements. Transgender women on feminizing therapy showed a significant increase in hair counts per square centimeter, along with improved hair-related quality of life. Transgender men on masculinizing therapy did not show a statistically significant change in overall hair counts during the same period, but there was a decrease in large terminal hairs on the scalp, likely reflecting testosterone accelerating early pattern baldness in those with a genetic tendency.19Journal of the American Academy of Dermatology. Scalp hair parameter changes in transgender individuals commencing gender-affirming hormone therapy: A 24-week prospective observational study A multicenter European study observed that in transgender men, facial and body hair scores increased significantly over time with testosterone, while in transgender women, facial hair scores decreased, though more than half still had notable facial hair after 12 months.20PubMed Central. Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
These findings underscore that hormonal shifts can meaningfully alter hair patterns, but the changes happen gradually and genetic predisposition still plays a large role. Transgender men who do not carry the genetic susceptibility for pattern baldness may grow more facial hair on testosterone without losing scalp hair, while those who do carry that susceptibility may experience thinning. The hormone sets the conditions; the genetics determine the response.
Medications That Work Through Hormonal Pathways
The most widely prescribed drugs for androgenetic alopecia work by intercepting the hormonal pathway at the enzyme level. Finasteride blocks type II 5-alpha reductase, the enzyme that converts testosterone to DHT. Dutasteride blocks both type I and type II forms of the enzyme, which theoretically provides broader suppression of DHT production.21PubMed. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study Both drugs can slow hair loss and, in many cases, partially reverse miniaturization, though they need to be taken continuously to maintain the effect.
Anti-androgen medications like spironolactone are sometimes used in women with pattern hair loss, particularly when PCOS or another androgen-excess condition is involved. Hormonal contraceptives can also help by reducing circulating androgens and raising sex hormone-binding globulin, which ties up free testosterone. On the opposite end, minoxidil, the other mainstay of hair loss treatment, works through a different mechanism that is not primarily hormonal, though it may interact with local growth factor signaling. The fact that the most effective pharmacological options directly target the androgen pathway is itself strong evidence of how central hormones are to the process.
Seasonal Cycles and the Evolutionary Angle
Humans do not molt, but many mammals undergo dramatic seasonal hair changes driven by hormonal shifts. In the European badger, for instance, the seasonal molt is regulated by both thyroid and gonadal hormones, which are themselves governed by the hypothalamus and pituitary gland in response to changing day length.22PubMed. Thyroid and gonadal regulation of hair growth during the seasonal molt in the male European badger, Meles meles L. The photoperiod, meaning how many hours of daylight the animal experiences, acts as the master synchronizer that tells the endocrine system when to trigger coat growth and shedding.
Humans have largely lost the dramatic seasonal coat changes our distant ancestors likely had, but subtle seasonal variations in hair shedding have been documented, with some studies finding slightly higher rates of hair loss in late summer and fall. The underlying hormonal machinery that drives seasonal molting in other mammals, the interplay between thyroid hormones, sex hormones, and light exposure, still exists in our biology. It is just dialed down. This is part of why melatonin, which is directly regulated by light exposure, has drawn interest as a hair growth modulator: it may be tapping into ancient hormonal circuitry that once controlled far more dramatic hair cycling than what we experience today.